Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Tryptophan fluorescence enables earlier cataract diagnosis

Jul 2011
Compiled by BioPhotonics staff

A widely used method of monitoring protein changes in biophysical research could become a clinically useful tool sensitive enough to diagnose cataracts before significant damage, light scattering, aggregation and visual impairment occur.

Cataracts are the leading cause of blindness worldwide, affecting 17 million people and resulting in 1.3 million operations annually in the US alone, according to the World Health Organization.

Researchers at Edinburgh Instruments (EI), NHS Princess Alexandra Eye Pavilion and Heriot-Watt University have explored the possibility of early cataract detection by using tryptophan fluorescence, which can detect protein folding, conformation and aggregation by virtue of shifts in the emission spectrum in different polar microenvironments.

Experiments with artificially created cataract lenses from pigs’ eyes – made by means of ultraviolet radiation – have shown that tryptophan fluorescence offers a sensitive method for monitoring very early changes in the lens structure that cannot be detected by the standard slit-lamp method. Spectral measurements were taken using an EI FLS920 spectrometer in a temperature-controlled 1-cm quartz cuvette in phosphate buffer solution at 22 °C, retaining uniform tissue viability over 16 hours.

Current methods for cataract detection are based on subjective observation of lens opacity by Rayleigh light scattering. This method does not provide the protein-level detail offered by tryptophan fluorescence, however, because of limitations of the scattering techniques, so it cannot reveal structural changes on a molecular level.

The new technique could help researchers establish the point at which the irreversible crystalline protein change that triggers the need for surgical intervention occurs. Clinical application of the method also will help in diagnosing early stages of metabolic disorders, such as diabetes, and in deciding on preventive treatment.

The study was published in the March 31, 2011, issue of the Journal of the Royal Society Interface (doi:10.1098/ rsif.2010.0608).

aggregationBiophotonicsbiophysical resarchBioScancataract detectioncataract diagnosticscrystalline proteindiabetesEdinburgh InstrumentsEIEI FLS920 spectrometerEnglandEuropeHeriot-Watt Universitylens changeslenseslight scatteringmetabolic disordersNewsNHS Princess Alexandra Eye Pavilionopticsprotein changeprotein foldingRayleigh light scatteringspectral measurementspectroscopyTFtryptophan fluorescenceultraviolet radiationvisual impairmentWorld Health Organization

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.